疼痛管理デバイス市場：デバイスタイプ、用途、流通チャネル、エンドユーザー、購入形態別-2025-2030年世界予測

疼痛管理デバイス市場の2023年の市場規模は33億7,000万米ドルで、2024年にはCAGR 8.79%で36億5,000万米ドルに成長し、2030年には60億8,000万米ドルに達すると予測されています。

今日の進化する医療情勢において、疼痛管理機器は様々な疼痛関連疾患に苦しむ患者にとって、治療継続の重要な柱として浮上してきました。同市場は、技術の急速な進歩、慢性疼痛や術後疼痛の有病率の増加、従来の薬理学的介入に代わるものへのニーズの高まりによって定義されています。深い研究開発投資と臨床共同研究によって推進される機器技術の革新は、ヘルスケア提供者の疼痛管理へのアプローチ方法を再構築しています。この変化は、患者の安全性と転帰を向上させるだけでなく、メーカーやヘルスケア施設にも新たな収益源をもたらしています。

電気刺激、磁気療法、ラジオ波焼灼装置などの先進的な治療法の導入は、従来の疼痛管理プロトコルに変革をもたらしつつあります。ヘルスケアシステムが世界的に高齢化と慢性疾患の増加という複雑な問題に取り組む中、非侵襲的で低侵襲な疼痛管理ソリューションへの依存はますます顕著になっています。さらに、デジタルヘルス製品とコネクテッドデバイスの統合は、臨床医に患者モニタリングの改善と個別化された治療経路を提供し、この市場セグメントの重要性を強化しています。

本レポートでは、様々な臨床現場における疼痛管理機器の導入に影響を与える現在の動向、画期的な技術、市場促進要因について詳細に分析しています。この分野の既存企業と新興企業の両方に焦点を当てた分析により、意思決定者は市場力学と将来の成長可能性を包括的に理解することができます。

疼痛管理デバイス市場の変革

近年、疼痛管理機器を取り巻く環境は、従来の治療方法から、より洗練された技術主導のソリューションへと変化しています。顕著な動向は製品ポートフォリオの進化であり、メーカー各社は精密さ、制御の強化、患者の転帰改善を実現する機器への投資を増やしています。この進化は、初歩的な機械的鎮痛システムから、接続機能、遠隔モニタリング、使いやすさの向上を統合した高度なデジタル機器への移行によって強調されています。

技術革新は、より統合された疼痛管理ソリューションへの移行を促進し続けています。臨床医は現在、痛みの発生源に対処するだけでなく、診断的フィードバックやデータ解析を提供し、患者ごとに治療法を改良する機器を一般的に採用しています。さらに、マイクロプロセッサー技術を取り入れることで、可変強度の電気刺激やオーダーメイドの高周波治療といった微妙な治療が可能になり、これらの治療法の有効性と安全性の両方が向上しています。このダイナミックな進化は、規制当局が医療機器技術の飛躍的進歩に対応するために承認プロセスを合理化し、市場投入と臨床導入を加速していることによって、さらに後押しされています。

もう一つの大きな変化は、個別化医療への関心の高まりです。センサー技術とウェアラブルデバイスの進歩により、リアルタイムフィードバックと患者データの統合が容易になり、患者の反応に基づいて治療方針が継続的に最適化されるようになりました。ヘルスケアプロバイダーがバリューベースのケアモデルを重視し続ける中、生活の質の一貫した測定可能な改善を提供できる機器に対する需要は、今後ますます強まることが予想されます。このことは、業界各社が継続的にイノベーションを行い、臨床医と患者双方の進化するニーズに自社のソリューションを合致させることが戦略上不可欠であることを強調しています。

疼痛管理デバイスの主要セグメント分析

市場セグメンテーションの詳細な分析により、疼痛管理機器市場の包括的な理解に寄与する複数の重要な層が明らかになりました。デバイスのタイプ別に見ると、鎮痛薬注入ポンプ、電気刺激デバイス、磁気治療デバイス、高周波アブレーションデバイスなど、さまざまな技術があることがわかる。例えば、鎮痛輸液ポンプは髄腔内ポンプと患者制御鎮痛ポンプに細分化され、電気刺激装置は微弱電流治療装置、神経筋電気刺激装置、経皮的電気神経刺激装置を含みます。同様に、ラジオ波焼灼療法はバイポーラ、モノポーラ、パルスに分けられ、それぞれ臨床上の利点が異なります。

アプリケーションの観点から見ると、市場はがん疼痛管理、月経痛管理、筋骨格系疼痛管理、神経障害性疼痛管理、術後疼痛管理などの分野に分類されます。筋骨格系の分野では、さらに関節炎性疼痛と腰痛に分けられ、術後疼痛管理では術後の急性疼痛と慢性疼痛に分けられます。このセグメンテーションは、疼痛管理機器が幅広い臨床シナリオに対応し、それぞれにユニークな患者の要求を満たす汎用性があることを強調しています。

販売チャネル別のセグメンテーションでは、オフラインとオンラインを区別し、進化する患者の購買行動と販売戦略の変化を強調しています。エンドユーザーのセグメンテーションでは、在宅ケア、病院・診療所、長期ケアセンターなど、ケア環境に基づいて市場をさらに細分化します。在宅ケアは慢性疾患と手術後の在宅ケアに分けられ、病院とクリニックは中立クリニックとペインクリニックに区別されます。長期ケアセンターはさらにホスピスとナーシングホームに区分され、それぞれ独自の運営需要と患者数を反映しています。最後に、購入形態を市販薬チャネルと処方薬チャネルにセグメンテーションすることで、市場成長を促進または抑制する規制と消費者行動の側面を示しています。

この多層的なセグメンテーションの枠組みは、疼痛管理機器市場の多様性を浮き彫りにするだけでなく、特定の患者ニーズをターゲットにした戦略の調整、流通チャネルの最適化、製品提供の強化を可能にします。このセグメンテーションから引き出される考察は、ターゲットを絞ったマーケティング戦略の開発や、競合情勢下での製品開発パイプラインの効率化を目指す利害関係者にとって有益です。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • スポーツ傷害や整形外科疾患の増加により、標的を絞った痛みの緩和に対する需要が高まっている
    • 個別化された在宅疼痛管理療法に対する患者の嗜好の増加
    • 慢性疼痛の世界の増加と技術革新により、疼痛管理デバイスの需要が高まっています。
  • 抑制要因
    • 技術的な制限により、疼痛管理デバイスの採用と有効性が妨げられている
  • 機会
    • AIと機械学習を活用して疼痛管理デバイスソリューションの有効性を高める
    • 遠隔医療の統合を活用して疼痛管理デバイスのアクセス性を拡大
  • 課題
    • 進化する規制課題を克服するための戦略的アプローチ疼痛管理デバイス市場
• 市場セグメンテーション分析
  • デバイスの種類：疼痛管理のための低侵襲オプションとして、高周波アブレーション（RFA）デバイスの需要が高まっています。
  • 応用：慢性疼痛管理のための神経障害性疼痛管理における疼痛管理デバイスの使用増加
  • 流通チャネル：若くテクノロジーに精通した世代による疼痛管理デバイス向けオンラインプラットフォームの採用増加
  • エンドユーザー：在宅ヘルスケアソリューションに対する消費者の嗜好の高まり
  • 購入方法：OTC疼痛管理デバイスは予防ヘルスケアソリューションを求める消費者の動向を補完します
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 疼痛管理デバイス市場：デバイスタイプ別

• 鎮痛剤注入ポンプ
  • 脊髄内ポンプ
  • 患者自己制御鎮痛ポンプ
• 電気刺激装置
  • マイクロカレント療法E-Stimデバイス
  • 神経筋電気刺激
  • 経皮的電気神経刺激
• 磁気治療装置
• 高周波アブレーション装置
  • バイポーラRFアブレーション
  • モノポーラRFアブレーション
  • パルスRFアブレーション

第7章 疼痛管理デバイス市場：用途別

• がん疼痛管理
• 月経疼痛管理
• 筋骨格系疼痛管理
  • 関節炎の痛み
  • 腰痛
• 神経障害性疼痛管理
• 術後疼痛管理
  • 急性術後疼痛
  • 慢性的な外科的疼痛

第8章 疼痛管理デバイス市場：流通チャネル別

• オフライン
• オンライン

第9章 疼痛管理デバイス市場：エンドユーザー別

• 在宅ケア設定
  • 慢性疾患の在宅ケア
  • 術後のホームケア
• 病院と診療所
  • 中立クリニック
  • ペインクリニック
• 長期ケアセンター
  • ホスピス
  • 介護施設

第10章 疼痛管理デバイス市場購入方法別

• 店頭
• 処方箋に基づく

第11章 南北アメリカの疼痛管理デバイス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の疼痛管理デバイス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの疼痛管理デバイス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析, 2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• AVACEN, Inc.
• Avanos Medical, Inc.
• B. Braun SE
• BioElectronics Corporation
• Boston Scientific Corporation
• CEFALY Technology
• Enovis Corporation
• Healthmate International, LLC
• HMS Medical Systems
• ICU Medical, Inc.
• iTENS, LLC
• Johari Digital
• Kimberly-Clark Corporation
• Medtronic PLC
• Multi Radiance Medical, Inc.
• NeuroMetrix, Inc.
• Nevro Corp.
• OMRON Healthcare, Inc.
• Oska Wellness
• Pain Care Labs
• Pain Management Technologies, Inc.
• Pfizer, Inc.
• Sanofi S.A.
• Stryker Corporation
• Ultracare Pro by Zealmax Innovations Pvt. Ltd.
• Zynex, Inc.

LIST OF FIGURES

• FIGURE 1. PAIN MANAGEMENT DEVICES MARKET MULTI-CURRENCY
• FIGURE 2. PAIN MANAGEMENT DEVICES MARKET MULTI-LANGUAGE
• FIGURE 3. PAIN MANAGEMENT DEVICES MARKET RESEARCH PROCESS
• FIGURE 4. PAIN MANAGEMENT DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 5. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2023 VS 2030 (%)
• FIGURE 17. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. UNITED STATES PAIN MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 21. UNITED STATES PAIN MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 25. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 26. PAIN MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 27. PAIN MANAGEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PAIN MANAGEMENT DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PAIN MANAGEMENT DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY INTRATHECAL PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PATIENT-CONTROLLED ANALGESIA PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MICROCURRENT THERAPY E-STIM DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROMUSCULAR ELECTRICAL STIMULATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MAGNETIC THERAPY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY BIPOLAR RF ABLATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MONOPOLAR RF ABLATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PULSED RF ABLATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CANCER PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MENSTRUAL PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ARTHRITIS PAIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY BACK PAIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROPATHIC PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ACUTE POST-SURGICAL PAIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CHRONIC SURGICAL PAIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CHRONIC ILLNESS HOME CARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-SURGERY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 44. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUTRAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 45. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PAIN CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 46. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 47. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 48. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 49. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NURSING HOMES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 50. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
• TABLE 51. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 52. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY OVER-THE-COUNTER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 53. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PRESCRIPTION-BASED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 54. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 55. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 56. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 57. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 58. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 60. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 61. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 62. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 63. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
• TABLE 64. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 65. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
• TABLE 66. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 67. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 68. ARGENTINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 69. ARGENTINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 70. ARGENTINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 71. ARGENTINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 72. ARGENTINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. ARGENTINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 74. ARGENTINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 75. ARGENTINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 76. ARGENTINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 77. ARGENTINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
• TABLE 78. ARGENTINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 79. ARGENTINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
• TABLE 80. ARGENTINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 81. BRAZIL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 82. BRAZIL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 83. BRAZIL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 84. BRAZIL PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 85. BRAZIL PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. BRAZIL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 87. BRAZIL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 88. BRAZIL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 89. BRAZIL PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. BRAZIL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
• TABLE 91. BRAZIL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 92. BRAZIL PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
• TABLE 93. BRAZIL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 94. CANADA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 95. CANADA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 96. CANADA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 97. CANADA PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 98. CANADA PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. CANADA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 100. CANADA PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 101. CANADA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 102. CANADA PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 103. CANADA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
• TABLE 104. CANADA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 105. CANADA PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
• TABLE 106. CANADA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 107. MEXICO PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 108. MEXICO PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 109. MEXICO PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 110. MEXICO PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 111. MEXICO PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. MEXICO PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 113. MEXICO PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 114. MEXICO PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 115. MEXICO PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 116. MEXICO PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
• TABLE 117. MEXICO PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 118. MEXICO PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
• TABLE 119. MEXICO PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 120. UNITED STATES PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 121. UNITED STATES PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 122. UNITED STATES PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 123. UNITED STATES PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 124. UNITED STATES PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. UNITED STATES PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 126. UNITED STATES PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 127. UNITED STATES PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 128. UNITED STATES PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 129. UNITED STATES PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
• TABLE 130. UNITED STATES PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 131. UNITED STATES PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
• TABLE 132. UNITED STATES PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 133. UNITED STATES PAIN MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 134. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 135. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 136. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 137. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 138. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 140. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 141. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 142. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 143. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
• TABLE 144. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 145. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
• TABLE 146. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 147. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 148. AUSTRALIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 149. AUSTRALIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 150. AUSTRALIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 151. AUSTRALIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 152. AUSTRALIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. AUSTRALIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 154. AUSTRALIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 155. AUSTRALIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 156. AUSTRALIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 157. AUSTRALIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
• TABLE 158. AUSTRALIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 159. AUSTRALIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
• TABLE 160. AUSTRALIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 161. CHINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 162. CHINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 163. CHINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 164. CHINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 165. CHINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. CHINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 167. CHINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 168. CHINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 169. CHINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 170. CHINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
• TABLE 171. CHINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 172. CHINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
• TABLE 173. CHINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 174. INDIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 175. INDIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 176. INDIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 177. INDIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 178. INDIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. INDIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 180. INDIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 181. INDIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 182. INDIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 183. INDIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
• TABLE 184. INDIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 185. INDIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
• TABLE 186. INDIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 187. INDONESIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 188. INDONESIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 189. INDONESIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 190. INDONESIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 191. INDONESIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 192. INDONESIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 193. INDONESIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 194. INDONESIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 195. INDONESIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 196. INDONESIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
• TABLE 197. INDONESIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 198. INDONESIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
• TABLE 199. INDONESIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 200. JAPAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 201. JAPAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 202. JAPAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 203. JAPAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 204. JAPAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 205. JAPAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 206. JAPAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 207. JAPAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 208. JAPAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 209. JAPAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
• TABLE 210. JAPAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 211. JAPAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
• TABLE 212. JAPAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 213. MALAYSIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 214. MALAYSIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 215. MALAYSIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 216. MALAYSIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 217. MALAYSIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 218. MALAYSIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 219. MALAYSIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 220. MALAYSIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 221. MALAYSIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 222. MALAYSIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
• TABLE 223. MALAYSIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 224. MALAYSIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
• TABLE 225. MALAYSIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 226. PHILIPPINES PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 227. PHILIPPINES PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 228. PHILIPPINES PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 229. PHILIPPINES PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 230. PHILIPPINES PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 231. PHILIPPINES PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 232. PHILIPPINES PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 233. PHILIPPINES PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 234. PHILIPPINES PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 235. PHILIPPINES PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
• TABLE 236. PHILIPPINES PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 237. PHILIPPINES PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
• TABLE 238. PHILIPPINES PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 239. SINGAPORE PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 240. SINGAPORE PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 241. SINGAPORE PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 242. SINGAPORE PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 243. SINGAPORE PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 244. SINGAPORE PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 245. SINGAPORE PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 246. SINGAPORE PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 247. SINGAPORE PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 248. SINGAPORE PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
• TABLE 249. SINGAPORE PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 250. SINGAPORE PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
• TABLE 251. SINGAPORE PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 252. SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 253. SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 254. SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 255. SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 256. SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 257. SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 258. SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 259. SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 260. SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 261. SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
• TABLE 262. SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 263. SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
• TABLE 264. SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 265. TAIWAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 266. TAIWAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 267. TAIWAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 268. TAIWAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 269. TAIWAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 270. TAIWAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 271. TAIWAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 272. TAIWAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 273. TAIWAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 274. TAIWAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
• TABLE 275. TAIWAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 276. TAIWAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
• TABLE 277. TAIWAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 278. THAILAND PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 279. THAILAND PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 280. THAILAND PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 281. THAILAND PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 282. THAILAND PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 283. THAILAND PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 284. THAILAND PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 285. THAILAND PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 286. THAILAND PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 287. THAILAND PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
• TABLE 288. THAILAND PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 289. THAILAND PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
• TABLE 290. THAILAND PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 291. VIETNAM PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 292. VIETNAM PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 293. VIETNAM PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 294. VIETNAM PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 295. VIETNAM PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 296. VIETNAM PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 297. VIETNAM PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
• TABLE 298. VIETNAM PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 299. VIETNAM PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 300. VIETNAM PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
• TABLE 301. VIETNAM PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
• TABLE 302. VIETNAM PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
• TABLE 303. VIETNAM PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
• TABLE 304. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 305. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
• TABLE 306. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILL

The Pain Management Devices Market was valued at USD 3.37 billion in 2023 and is projected to grow to USD 3.65 billion in 2024, with a CAGR of 8.79%, reaching USD 6.08 billion by 2030.

In today's evolving medical landscape, pain management devices have emerged as a critical pillar in the treatment continuum for patients suffering from various pain-related conditions. The market is defined by rapid advancements in technology, the increasing prevalence of chronic and post-operative pain, and a growing need for alternatives to traditional pharmacological interventions. Innovation in device technology, driven by deep R&D investments and clinical collaborations, is reshaping how healthcare providers approach pain management. This shift is not only enhancing patient safety and outcomes but is also offering new revenue streams for manufacturers and healthcare facilities alike.

The introduction of advanced therapies such as electrical stimulation, magnetic therapy, and radiofrequency ablation devices is transforming conventional pain management protocols. As healthcare systems globally contend with the complexities of an aging population and rising incidences of chronic illnesses, the reliance on non-invasive and minimally invasive pain management solutions becomes ever more pronounced. Furthermore, the integration of digital health offerings and connected devices provides clinicians with improved patient monitoring and personalized treatment pathways, reinforcing the importance of this market segment.

This report conducts an in-depth analysis of current trends, breakthrough technologies, and market drivers that are influencing the deployment of pain management devices across various clinical settings. With a focus on both established and emerging players in the field, the analysis provides decision-makers with a comprehensive understanding of the market dynamics and future growth potentials.

Transformative Shifts in the Pain Management Devices Landscape

Recent years have witnessed a series of transformative shifts in the landscape of pain management devices, catalyzing a departure from traditional treatment modalities to more sophisticated, technology-driven solutions. A marked trend is the evolution of product portfolios, with manufacturers increasingly investing in devices that offer precision, enhanced control, and improved patient outcomes. This evolution is underscored by a transition from rudimentary mechanical pain relief systems to advanced digital devices that integrate connectivity features, remote monitoring, and enhanced usability.

Technological innovation continues to drive the transition towards more integrated pain management solutions. Clinicians now commonly employ devices that not only address pain at its source but also provide diagnostic feedback and data analytics to refine therapy on a patient-specific basis. Moreover, the incorporation of microprocessor technologies has enabled devices to deliver nuanced therapies such as variable intensity electrical stimulation and tailored radiofrequency treatments, increasing both the efficacy and safety profile of these interventions. This dynamic evolution is further bolstered by regulatory bodies streamlining approval processes to accommodate breakthroughs in medical device technology, thus accelerating time-to-market and clinical adoption.

Another significant shift in the landscape is driven by a heightened focus on personalized care. Advancements in sensor technology and wearable devices facilitate real-time feedback and patient data integration, ensuring that treatment regimes are continually optimized based on patient response. As healthcare providers continue to emphasize value-based care models, the demand for devices that can deliver consistent, measurable improvements in quality of life is set to intensify. This underscores the strategic imperative for industry players to continuously innovate and align their solutions with the evolving needs of both clinicians and patients.

Key Segmentation Insights in Pain Management Devices

A detailed analysis of market segmentation reveals multiple critical layers that contribute to a comprehensive understanding of the pain management devices market. An examination based on device type uncovers a rich tapestry of technologies such as analgesic infusion pumps, electrical stimulation devices, magnetic therapy devices, and radiofrequency ablation devices. These categories are further nuanced; for example, analgesic infusion pumps are subdivided into intrathecal pumps and patient-controlled analgesia pumps, while electrical stimulation devices encompass microcurrent therapy devices, neuromuscular electrical stimulation, and transcutaneous electrical nerve stimulation. Similarly, the radiofrequency ablation segment divides into bipolar, monopolar, and pulsed techniques, each offering distinct clinical advantages.

When viewed from an application standpoint, the market stratifies into areas like cancer pain management, menstrual pain management, musculoskeletal pain management, neuropathic pain management, and post-operative pain management. In the musculoskeletal arena, the focus further divides into arthritis pain and back pain, while post-operative pain management differentiates between acute post-surgical pain and chronic surgical pain. This segmentation underscores the versatility of pain management devices in addressing a broad spectrum of clinical scenarios, each with unique patient requirements.

Additional segmentation by distribution channel distinguishes between offline and online modes, highlighting evolving patient purchasing behaviors and changing distribution strategies. The end user segmentation further delineates the market based on care settings, including home care, hospitals and clinics, and long-term care centers. Home care is dissected into chronic illness and post-surgery home care, whereas hospitals and clinics are differentiated into neutral clinics and pain clinics. Long-term care centers are further segmented into hospices and nursing homes, each reflecting unique operational demands and patient populations. Lastly, the mode of purchase segmentation into over-the-counter and prescription-based channels illustrates the regulatory and consumer behavior dimensions that either facilitate or constrain market growth.

This multi-layered segmentation framework not only highlights the diversity within the pain management devices market but also enables players to tailor their strategies to target specific patient needs, optimize distribution channels, and enhance product offerings. The insights drawn from this segmentation are instrumental for stakeholders aiming to develop targeted marketing initiatives and to streamline product development pipelines in a competitive landscape.

Based on Device Type, market is studied across Analgesic Infusion Pumps, Electrical Stimulation Devices, Magnetic Therapy Devices, and Radiofrequency Ablation Devices. The Analgesic Infusion Pumps is further studied across Intrathecal Pumps and Patient-Controlled Analgesia Pumps. The Electrical Stimulation Devices is further studied across Microcurrent Therapy E-Stim Devices, Neuromuscular Electrical Stimulation, and Transcutaneous Electrical Nerve Stimulation. The Radiofrequency Ablation Devices is further studied across Bipolar RF Ablation, Monopolar RF Ablation, and Pulsed RF Ablation.

Based on Application, market is studied across Cancer Pain Management, Menstrual Pain Management, Musculoskeletal Pain Management, Neuropathic Pain Management, and Post-Operative Pain Management. The Musculoskeletal Pain Management is further studied across Arthritis Pain and Back Pain. The Post-Operative Pain Management is further studied across Acute Post-Surgical Pain and Chronic Surgical Pain.

Based on Distribution Channel, market is studied across Offline and Online.

Based on End User, market is studied across Home Care Settings, Hospitals And Clinics, and Long-Term Care Centers. The Home Care Settings is further studied across Chronic Illness Home Care and Post-Surgery Home Care. The Hospitals And Clinics is further studied across Neutral Clinics and Pain Clinics. The Long-Term Care Centers is further studied across Hospices and Nursing Homes.

Based on Mode of Purchase, market is studied across Over-the-counter and Prescription-based.

Regional Insights in the Global Pain Management Devices Market

The global market exhibits distinct regional nuances that significantly impact growth trajectories and investment opportunities. In the Americas, particularly within the United States and Canada, the mature healthcare infrastructure combined with high healthcare expenditure and an aging population has led to robust growth in the adoption of advanced pain management devices. Regions in the Americas are characterized by extensive clinical research, favorable reimbursement policies, and a high acceptance of innovative medical technologies. This has paved the way for rapid clinical integration and widespread use of sophisticated therapies that optimize patient outcomes.

Moving to Europe, the Middle East, and Africa, a blend of diverse healthcare systems and regulatory environments presents both challenges and opportunities. European countries, with their stringent regulatory frameworks and early adoption of cutting-edge healthcare solutions, serve as a bellwether for market trends, while emerging markets in the Middle East and Africa are beginning to harness innovative technologies to improve pain management. These regions are increasingly investing in healthcare infrastructure, driven by rising demand and the need to address chronic and post-operative pain in a cost-effective manner. The gradual harmonization of medical standards across these geographically and economically diverse regions is expected to foster a conducive environment for the accelerated adoption of advanced pain management solutions.

In the Asia-Pacific, dynamic economic growth, rapid urbanization, and increasing healthcare awareness are propelling the demand for pain management devices. Countries within this region are witnessing a surge in investments in healthcare technology, with a focus on integrating state-of-the-art devices that address both acute and chronic pain conditions. The region's market is particularly notable for its emphasis on cost-effective and scalable solutions that can cater to both high-end hospital settings and home-based care. This combination of affordability, improved accessibility, and technological innovation is setting the stage for significant market expansion in the coming years.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Competitive Landscape and Key Company Insights

A robust competitive environment defines the pain management devices market, with a mix of multinational corporations and agile innovators continually shaping market dynamics. Industry leaders such as Abbott Laboratories, AVACEN, Inc., and Avanos Medical, Inc. have demonstrated unwavering commitment to clinical excellence and technological innovation. Companies like B. Braun SE and BioElectronics Corporation are recognized for their advanced portfolio of products that cater to a diverse range of clinical applications, effectively addressing the multifaceted needs of pain management.

Notable players, including Boston Scientific Corporation and CEFALY Technology, have carved out a niche by delivering solutions that fuse cutting-edge technology with precise clinical performance. Other key companies such as Enovis Corporation and Healthmate International, LLC are pioneering developments that enhance patient comfort and provide data-driven insights to clinicians. HMS Medical Systems, ICU Medical, Inc., and iTENS, LLC have reinforced their market positions by introducing devices that offer superior reliability and adaptability in various clinical settings.

The competitive landscape is further enriched by innovators like Johari Digital and Kimberly-Clark Corporation, who continue to expand their footprint in the pain management arena through strategic initiatives and product diversification. Medtronic PLC and Multi Radiance Medical, Inc. contribute to the market's growth by investing significantly in research and development, consistently driving technological advancements. Companies such as NeuroMetrix, Inc. and Nevro Corp. have made notable strides in leveraging neuromodulation therapies to enhance pain relief effectiveness.

Other influential players, including OMRON Healthcare, Inc. and Oska Wellness, have augmented their portfolios with specialized devices that offer targeted pain relief solutions. Emerging companies like Pain Care Labs and Pain Management Technologies, Inc. are also gaining traction by addressing niche market segments with innovative approaches. Industry giants like Pfizer, Inc., Sanofi S.A., and Stryker Corporation round out the competitive landscape by combining extensive research capabilities with expansive distribution networks, thereby ensuring a consistent pipeline of next-generation devices. Likewise, Ultracare Pro by Zealmax Innovations Pvt. Ltd. and Zynex, Inc. continue to push the envelope with novel therapeutic technologies that address both acute and chronic pain conditions. The sustained focus on innovation and quality underscores the market's commitment to delivering effective and safe pain management solutions, cementing the role of these key players in shaping future trends.

The report delves into recent significant developments in the Pain Management Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AVACEN, Inc., Avanos Medical, Inc., B. Braun SE, BioElectronics Corporation, Boston Scientific Corporation, CEFALY Technology, Enovis Corporation, Healthmate International, LLC, HMS Medical Systems, ICU Medical, Inc., iTENS, LLC, Johari Digital, Kimberly-Clark Corporation, Medtronic PLC, Multi Radiance Medical, Inc., NeuroMetrix, Inc., Nevro Corp., OMRON Healthcare, Inc., Oska Wellness, Pain Care Labs, Pain Management Technologies, Inc., Pfizer, Inc., Sanofi S.A., Stryker Corporation, Ultracare Pro by Zealmax Innovations Pvt. Ltd., and Zynex, Inc.. Actionable Recommendations for Industry Leaders

In light of the evolving competitive dynamics and market segmentation insights, industry leaders are advised to adopt a multi-pronged strategy that encompasses both innovation and strategic collaboration. Investing in research and development to enhance product efficacy and safety remains paramount, particularly in exploring advanced device functionalities that integrate digital monitoring and data analytics. Decision-makers should also consider diversifying product portfolios to address the nuanced requirements underscored by varying device types, applications, and care settings. Such a diversified approach not only positions companies to capture emerging market segments but also mitigates risks associated with the rapid pace of technological disruption.

To stay ahead in an increasingly competitive environment, companies should strategically harness insights from regional market trends. Embracing a localized strategy that caters to the specific regulatory, economic, and cultural landscapes of regions such as the Americas, Europe, the Middle East & Africa, and Asia-Pacific will foster greater market penetration. This requires a blend of targeted marketing efforts, tailored product offerings, and flexible pricing strategies that resonate with localized demand. Emphasis should also be placed on enhancing distribution channels, including leveraging both online and offline methodologies, to ensure wider market access and improved customer engagement.

Collaboration with academic institutions and key opinion leaders can yield valuable insights that guide innovation and clinical validation. Such partnerships not only bolster the credibility of new technologies but also facilitate quicker adoption within clinical practices. Additionally, aligning with regulatory bodies and industry associations may provide the necessary support to navigate complex market dynamics and to expedite the approval process for breakthrough pain management devices.

Furthermore, a robust post-market surveillance system is essential to track device performance and gather real-world evidence, enabling the continuous refinement of therapeutic solutions. This iterative approach, combined with strategic investments in digital health ecosystems, will empower companies to provide value-added services that extend beyond the initial sale of devices. By integrating telemedicine and remote monitoring capabilities, companies can enhance patient support, optimize therapeutic regimens, and drive long-term consumer satisfaction.

Overall, the recommended approach entails building a resilient and agile operational framework that embraces technological innovations, fosters strategic partnerships, and adapts to shifting market dynamics. This will not only secure a competitive edge in the ever-evolving landscape but also ensure sustainable growth and improved patient outcomes.

Conclusion: Charting a New Course in Pain Management

In summary, the pain management devices market is on the cusp of transformative growth, driven by rapid technological innovation and evolving clinical needs. The multifaceted segmentation across device type, application, distribution channel, end user, and mode of purchase highlights the diversity of demand and the opportunities to customize solutions for varied patient populations. This dynamic landscape, further enriched by regional economic trends and competitive innovation, underscores the imperative for industry leaders to remain agile, invest in advanced technologies, and foster collaborative ecosystems.

The insights presented demonstrate that a forward-thinking approach, one that blends robust R&D with localized strategies and enhanced digital offerings, is essential for sustaining market momentum. As the industry continues to evolve, a clear emphasis on personalized, data-driven, and patient-centric solutions will be the cornerstone of success in chronic and acute pain management. With pressing clinical demands and significant potential for improved patient outcomes, stakeholders are encouraged to leverage these insights to position themselves at the forefront of this innovative field.

Looking ahead, the confluence of clinical precision, technological advancements, and strategic market insights presents a compelling narrative for future investment and growth. The path forward is defined by continuous innovation, strategic agility, and an unwavering commitment to enhancing patient care.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rise in sports injuries and orthopedic conditions amplifying demand for targeted pain relief
    • 5.1.1.2. Increasing patient preference for personalized and home-based pain management therapies
    • 5.1.1.3. Growing demand for pain management devices driven by global rise in chronic pain prevalence and technological innovations
  • 5.1.2. Restraints
    • 5.1.2.1. Technological limitations hampers adoption and effectiveness of pain management devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Utilizing AI and machine learning to enhance the effectiveness of pain management device solutions
    • 5.1.3.2. Leveraging telehealth integration to expand pain management device accessibility
  • 5.1.4. Challenges
    • 5.1.4.1. Strategic approaches to overcome regulatory challenges in the evolving pain management devices market
• 5.2. Market Segmentation Analysis
  • 5.2.1. Device Type: Increasing demand for radiofrequency ablation (RFA) devices due to their minimally invasive options for pain management
  • 5.2.2. Application: Proliferating use of pain management devices in neuropathic pain management for chronic pain management
  • 5.2.3. Distribution Channel: Growing adoption of online platforms for pain management devices by young, tech-savy generation
  • 5.2.4. End User: Rising consumer preference for at-home healthcare solutions
  • 5.2.5. Mode of Purchase: OTC pain management devices complement consumer trends toward preventative healthcare solutions
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Pain Management Devices Market, by Device Type

• 6.1. Introduction
• 6.2. Analgesic Infusion Pumps
  • 6.2.1. Intrathecal Pumps
  • 6.2.2. Patient-Controlled Analgesia Pumps
• 6.3. Electrical Stimulation Devices
  • 6.3.1. Microcurrent Therapy E-Stim Devices
  • 6.3.2. Neuromuscular Electrical Stimulation
  • 6.3.3. Transcutaneous Electrical Nerve Stimulation
• 6.4. Magnetic Therapy Devices
• 6.5. Radiofrequency Ablation Devices
  • 6.5.1. Bipolar RF Ablation
  • 6.5.2. Monopolar RF Ablation
  • 6.5.3. Pulsed RF Ablation

7. Pain Management Devices Market, by Application

• 7.1. Introduction
• 7.2. Cancer Pain Management
• 7.3. Menstrual Pain Management
• 7.4. Musculoskeletal Pain Management
  • 7.4.1. Arthritis Pain
  • 7.4.2. Back Pain
• 7.5. Neuropathic Pain Management
• 7.6. Post-Operative Pain Management
  • 7.6.1. Acute Post-Surgical Pain
  • 7.6.2. Chronic Surgical Pain

8. Pain Management Devices Market, by Distribution Channel

• 8.1. Introduction
• 8.2. Offline
• 8.3. Online

9. Pain Management Devices Market, by End User

• 9.1. Introduction
• 9.2. Home Care Settings
  • 9.2.1. Chronic Illness Home Care
  • 9.2.2. Post-Surgery Home Care
• 9.3. Hospitals And Clinics
  • 9.3.1. Neutral Clinics
  • 9.3.2. Pain Clinics
• 9.4. Long-Term Care Centers
  • 9.4.1. Hospices
  • 9.4.2. Nursing Homes

10. Pain Management Devices Market, by Mode of Purchase

• 10.1. Introduction
• 10.2. Over-the-counter
• 10.3. Prescription-based

11. Americas Pain Management Devices Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Pain Management Devices Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Pain Management Devices Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Strategic collaboration between CANNORDIC and Nimbus Health with CBD-infused pain management solutions
  • 14.3.2. Nevro's innovative AI-driven spinal cord stimulation technology for personalized pain management solutions
  • 14.3.3. Hinge Health's new wireless pain relief device expected to transform digital health market
  • 14.3.4. Zynex Medical expands portfolio with TensWave to address insurance gaps in growing neuromodulation narket
  • 14.3.5. Stryker's Strategic Acquisition of Vertos Medical to Boost Minimally Invasive Pain Management Solutions
  • 14.3.6. Stryker Introduces MultiGen 2 RF Generator in India to enhance chronic joint pain management
  • 14.3.7. Medtronic introduces Inceptiv SCS for advanced pain management
  • 14.3.8. NeuroOne launches innovative OneRF Ablation System to bolster market position
  • 14.3.9. Zynex expands pain management solutions with innovative hybrid spinal support and portable cold compression launch
  • 14.3.10. FDA approval of Boston Scientific's WaveWriter SCS Systems expands non-surgical back pain solutions
• 14.4. Strategy Analysis & Recommendation
  • 14.4.1. Pfizer Inc.
  • 14.4.2. Stryker Corporation
  • 14.4.3. Medtronic PLC
  • 14.4.4. B. Braun SE
  • 14.4.5. Abbott Laboratories

Companies Mentioned

• 1. Abbott Laboratories
• 2. AVACEN, Inc.
• 3. Avanos Medical, Inc.
• 4. B. Braun SE
• 5. BioElectronics Corporation
• 6. Boston Scientific Corporation
• 7. CEFALY Technology
• 8. Enovis Corporation
• 9. Healthmate International, LLC
• 10. HMS Medical Systems
• 11. ICU Medical, Inc.
• 12. iTENS, LLC
• 13. Johari Digital
• 14. Kimberly-Clark Corporation
• 15. Medtronic PLC
• 16. Multi Radiance Medical, Inc.
• 17. NeuroMetrix, Inc.
• 18. Nevro Corp.
• 19. OMRON Healthcare, Inc.
• 20. Oska Wellness
• 21. Pain Care Labs
• 22. Pain Management Technologies, Inc.
• 23. Pfizer, Inc.
• 24. Sanofi S.A.
• 25. Stryker Corporation
• 26. Ultracare Pro by Zealmax Innovations Pvt. Ltd.
• 27. Zynex, Inc.